Gastroenterology

Latest News

Australian doctor and biosimilars | Image credit: Sandor Kacso - stock.adobe.com
Australian Patients With IBD Switched to Biosimilar Infliximab Maintain Long-Term Persistence

July 5th 2025

Long-term data from the SAME study confirm that switching to infliximab biosimilars is safe and effective for patients with inflammatory bowel disease (IBD).

Smart phone app that tracks medical data | Image Credit: Maksym - stock.adobe.com
Adalimumab Double Take: The Unexpected Return to Reference Humira

June 30th 2025

child with IBD | Image credit: Art_Photo - stock.adobe.com
Increasing Biosimilar Use Reflects Changing Practice in Pediatric IBD Care

June 25th 2025

child with IBD getting adalimumab biosimilar | Image credit: zinkevych - stock.adobe.com
Long-Term Durability and Cost-Effectiveness of Adalimumab Biosimilars in Pediatric IBD

June 22nd 2025

EOP thumbnail
Eye on Pharma: Keytruda Biosimilar Deal; German Court Bans Imraldi; New Biosimilars for Japan

June 17th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.